Fundraising Fox
Jecure Therapeutics
San Diego, US · Founded 2015 · Delaware corporation · 2 employees on LinkedIn · 1 known investors
Find your way into Jecure Therapeutics
Sign up to see every warm intro you have to Jecure Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Jecure Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JS
Jeffrey Stafford, Ph.D.Executive
JV
James Veal, Ph.D.Executive
AF
Ariel Feldstein, M.D.Named on SEC filing
Board
BB
Bradley Bolzon, Ph.D.Board director
TW
Thomas Woiwode, Ph.D.Board director
Investors · 1
Versant VenturesreportedSan Francisco · $250K – $5M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$18M disclosed across 2 rounds · 2017–2018
▶$3MraisedJul 2018 · 4 investors · BiotechnologyRule 506(b)
▶$3MraisedJul 2018 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey Stafford, Ph.D.Executive Officer, Director
- Thomas Woiwode, Ph.D.Director
- Bradley Bolzon, Ph.D.Director
- Ariel Feldstein, M.D.Director
- James Veal, Ph.D.Executive Officer
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$15MraisedDec 2017 · 4 investors · BiotechnologyRule 506(b)
▶$15MraisedDec 2017 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bradley Bolzon, Ph.D.Director
- Ariel Feldstein, M.D.Director
- Jeffrey Stafford, Ph.D.Executive Officer, Director
- James Veal, Ph.D.Executive Officer
- Thomas Woiwode, Ph.D.Director
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Jecure Therapeutics's investors?
- Jecure Therapeutics's investors include Versant Ventures.
- How much funding has Jecure Therapeutics raised?
- Jecure Therapeutics has disclosed $18M raised across 2 rounds.
- Where is Jecure Therapeutics headquartered?
- Jecure Therapeutics is headquartered in San Diego, US.